chr5-35037010-C-T
Position:
Variant summary
Our verdict is Benign. Variant got -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_031900.4(AGXT2):c.418G>A(p.Val140Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.142 in 1,614,008 control chromosomes in the GnomAD database, including 32,089 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Affects (no stars).
Frequency
Genomes: 𝑓 0.25 ( 8230 hom., cov: 33)
Exomes 𝑓: 0.13 ( 23859 hom. )
Consequence
AGXT2
NM_031900.4 missense
NM_031900.4 missense
Scores
18
Clinical Significance
Conservation
PhyloP100: 0.313
Genes affected
AGXT2 (HGNC:14412): (alanine--glyoxylate aminotransferase 2) The protein encoded by this gene is a class III pyridoxal-phosphate-dependent mitochondrial aminotransferase. It catalyzes the conversion of glyoxylate to glycine using L-alanine as the amino donor. It is an important regulator of methylarginines and is involved in the control of blood pressure in kidney. Polymorphisms in this gene affect methylarginine and beta-aminoisobutyrate metabolism, and are associated with carotid atherosclerosis. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Apr 2015]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -12 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=1.0213786E-4).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.563 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
AGXT2 | NM_031900.4 | c.418G>A | p.Val140Ile | missense_variant | 4/14 | ENST00000231420.11 | NP_114106.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
AGXT2 | ENST00000231420.11 | c.418G>A | p.Val140Ile | missense_variant | 4/14 | 1 | NM_031900.4 | ENSP00000231420.6 | ||
AGXT2 | ENST00000510428.1 | c.418G>A | p.Val140Ile | missense_variant | 4/13 | 1 | ENSP00000422799.1 | |||
AGXT2 | ENST00000618015.4 | c.418G>A | p.Val140Ile | missense_variant | 4/12 | 5 | ENSP00000479154.1 | |||
AGXT2 | ENST00000505542.1 | n.327G>A | non_coding_transcript_exon_variant | 3/5 | 2 |
Frequencies
GnomAD3 genomes AF: 0.253 AC: 38529AN: 152064Hom.: 8208 Cov.: 33
GnomAD3 genomes
AF:
AC:
38529
AN:
152064
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.210 AC: 52796AN: 251192Hom.: 9552 AF XY: 0.194 AC XY: 26272AN XY: 135752
GnomAD3 exomes
AF:
AC:
52796
AN:
251192
Hom.:
AF XY:
AC XY:
26272
AN XY:
135752
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.130 AC: 190486AN: 1461826Hom.: 23859 Cov.: 41 AF XY: 0.130 AC XY: 94892AN XY: 727224
GnomAD4 exome
AF:
AC:
190486
AN:
1461826
Hom.:
Cov.:
41
AF XY:
AC XY:
94892
AN XY:
727224
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.254 AC: 38595AN: 152182Hom.: 8230 Cov.: 33 AF XY: 0.255 AC XY: 18975AN XY: 74402
GnomAD4 genome
AF:
AC:
38595
AN:
152182
Hom.:
Cov.:
33
AF XY:
AC XY:
18975
AN XY:
74402
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
TwinsUK
AF:
AC:
308
ALSPAC
AF:
AC:
346
ESP6500AA
AF:
AC:
2374
ESP6500EA
AF:
AC:
734
ExAC
AF:
AC:
25570
Asia WGS
AF:
AC:
1438
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Affects
Submissions summary: Other:1
Revision: no assertion criteria provided
LINK: link
Submissions by phenotype
Beta-aminoisobutyric acid, urinary excretion of Other:1
Affects, no assertion criteria provided | literature only | OMIM | Jun 01, 2017 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
DEOGEN2
Benign
T;.;.
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Benign
N
LIST_S2
Benign
T;T;.
MetaRNN
Benign
T;T;T
MetaSVM
Benign
T
MutationAssessor
Benign
N;N;N
PrimateAI
Benign
T
PROVEAN
Benign
N;.;N
REVEL
Benign
Sift
Benign
T;.;T
Sift4G
Benign
T;T;T
Polyphen
B;.;.
Vest4
MPC
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at